Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia
Hubert H. Fernandez, Fernando Pagan, Fabio Danisi, David Greeley, Joseph Jankovic, Amit Verma, Kapil Sethi, Eric J. Pappert, XCiDaBLE Study Group
Introducing Virtual Shared Medical Appointments as a Novel Treatment Platform for Functional Movement Disorders
Saar Anis, Megan Zelinsky, Umar Shuaib, Emma Hartwig, Melissa Simpson, Hubert H. Fernandez, Taylor Rush, Xin Xin Yu
Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia
Hubert H. Fernandez, Eric J. Pappert, Cynthia L. Comella, Virgilio Gerald H. Evidente, Daniel D. Truong, Amit Verma, Joseph Jankovic
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm
Hubert H. Fernandez, Joseph Jankovic, John B. Holds, Daniel Lin, John Burns, Amit Verma, Kapil Sethi, Eric J. Pappert, on behalf of the XCiDaBLE Study Group
A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family
Oscar Bernal-Pacheco, Genko Oyama, Angela Briton, Andrew B. Singleton, Hubert H. Fernandez, Ramon L. Rodriguez, Irene A. Malaty, Michael S. Okun